CORRESP Filing
Dogwood Therapeutics, Inc.
Date: May 29, 2025 · CIK: 0001818844 · Accession: 0001104659-25-054284
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287575
Letter
Re: Dogwood Therapeutics, Inc.
DOGWOOD THERAPEUTICS, INC. 44 Milton Avenue Alpharetta, GA 30009
May 29, 2025
VIA EDGAR
Securities and Exchange Commission Division of Corporation Finance
100 F Street, N.E. Washington, DC 20549
File No. 333-287575
Registration Statement on Form S-3
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, or the Act, Dogwood Therapeutics, Inc., or the Company, requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-287575) be accelerated to 5:00 p.m. Eastern Time on June 2, 2025, or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
It would be appreciated if, promptly after the Registration Statement has become effective, you would so inform our outside counsel, Darrick Mix of Duane Morris LLP, by telephone at (215) 979-1206 or by email at dmix@duanemorris.com. The Company hereby authorizes Mr. Mix to orally modify or withdraw this request for acceleration.
Sincerely,
DOGWOOD THERAPEUTICS,
INC.
Show Raw Text
CORRESP 1 filename1.htm DOGWOOD THERAPEUTICS, INC. 44 Milton Avenue Alpharetta, GA 30009 May 29, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Dogwood Therapeutics, Inc. File No. 333-287575 Registration Statement on Form S-3 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, or the Act, Dogwood Therapeutics, Inc., or the Company, requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-287575) be accelerated to 5:00 p.m. Eastern Time on June 2, 2025, or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. It would be appreciated if, promptly after the Registration Statement has become effective, you would so inform our outside counsel, Darrick Mix of Duane Morris LLP, by telephone at (215) 979-1206 or by email at dmix@duanemorris.com. The Company hereby authorizes Mr. Mix to orally modify or withdraw this request for acceleration. Sincerely, DOGWOOD THERAPEUTICS, INC. By: /s/ Greg Duncan Greg Duncan Chairman and Chief Executive Officer